These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10817401)

  • 1. Effects of SCH 42495, a neutral endopeptidase inhibitor, on cardiac function and mass in rats after repeated hyperbaric exposures.
    Stuhr LE
    Scand J Clin Lab Invest; 2000 Apr; 60(2):141-8. PubMed ID: 10817401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Losartan, an angiotensin II antagonist, on cardiac function, mass and morphology in rats after repeated hyperbaric exposures.
    Stuhr LE; Maehle BO
    Scand J Clin Lab Invest; 1997 May; 57(3):253-61. PubMed ID: 9238761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated normoxic hyperbaric exposures induce haemodynamic and myocardial changes in rats.
    Stuhr LE; Bergø GW; Skei S; Maehle BO; Tyssebotn I
    Eur J Appl Physiol Occup Physiol; 1993; 66(3):226-34. PubMed ID: 8477678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neutral endopeptidase inhibitor, SCH 34826, reduces left ventricular hypertrophy in spontaneously hypertensive rats.
    Monopoli A; Ongini E; Cigola E; Olivetti G
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):496-504. PubMed ID: 1279298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the neutral endopeptidase inhibitor, SCH 42495, on the cardiovascular remodelling secondary to chronic hypoxia in rats.
    Thompson JS; Sheedy W; Morice AH
    Clin Sci (Lond); 1994 Jul; 87(1):109-14. PubMed ID: 8062513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
    Farina NK; Johnston CI; Burrell LM
    J Hypertens; 2000 Jun; 18(6):749-55. PubMed ID: 10872560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction.
    Marie C; Mossiat C; Lecomte JM; Schwartz JC; Bralet J
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1324-31. PubMed ID: 8531099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic hemodynamics during hyperbaric oxygen exposure in rats.
    Stuhr LE; Bergø GW; Tyssebotn I
    Aviat Space Environ Med; 1994 Jun; 65(6):531-8. PubMed ID: 8074627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats.
    Sala C; Monopoli A; Casati C; Ardeleani G; Ongini E; Zanchetti A; Morganti A
    J Cardiovasc Pharmacol; 1994 May; 23(5):703-8. PubMed ID: 7521451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia.
    Thompson JS; Sheedy W; Morice AH
    Br J Pharmacol; 1994 Dec; 113(4):1121-6. PubMed ID: 7889263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.
    Lainchbury JG; Richards AM; Nicholls MG; Espiner EA; Yandle TG
    J Clin Endocrinol Metab; 1999 Feb; 84(2):723-9. PubMed ID: 10022444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
    J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction.
    Yoshida K; Yasujima M; Casley DJ; Johnston CI
    Jpn Circ J; 1998 Sep; 62(9):680-6. PubMed ID: 9766707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cardiac contractility in rats exposed to 5 bar.
    Stuhr LE; Ask JA; Tyssebotn I
    Acta Physiol Scand; 1989 Jun; 136(2):167-76. PubMed ID: 2782090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man.
    Lainchbury JG; Nicholls MG; Espiner EA; Ikram H; Yandle TG; Richards AM
    Clin Sci (Lond); 1998 Nov; 95(5):547-55. PubMed ID: 9791040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
    Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
    J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of hyperbaric oxygen with and without addition of carbon dioxide.
    Bergo GW; Tyssebotn I
    Eur J Appl Physiol Occup Physiol; 1999 Sep; 80(4):264-75. PubMed ID: 10483795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inhibition of neutral endopeptidase reduces left ventricular hypertrophy without changing blood pressure in spontaneously hypertensive rats.
    Monopoli A; Forlani A; Ongini E
    J Hypertens Suppl; 1991 Dec; 9(6):S246-7. PubMed ID: 1840189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.